Searched for
FRESENIUS KABI SINGAPORE
Fresenius Kabi gets 2 months extension for delisting offerFresenius Kabi Oncology today said Securities Appellate Tribunal (SAT) has granted it an extension of two months to complete its delisting ...- Government clears 17 FDI proposals worth Rs 993 croreThe govt has approved 17 FDI proposals totalling Rs 992.61 cr, while recommending the Rs 2,058 cr Jet-Etihad deal for final clearance to Ca...
- Fifteen stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of fifteen stocks which are likely to remain in focus in morning trade.
- Fresenius plans to delist 7 months after OFS, raises concerns over Sebi norms 'violations'The move by theFKOL promoters to delist the shares of the company seven months after making an OFS has raised questions about the timing of...
- Promoters want to delist Fresenius Kabi Oncology from boursesFresenius Kabi (Singapore) Pte Ltd is planning to delist its Indian arm Fresenius Kabi Oncology by buying out 19 % stake held by the public.
- RBS acquires shares in 4 companies for over Rs 69 crThe shares were acquired in these companies from ABN Amro Bank through various bulk deals, shows data from bourses.
- Foreign Investment Promotion Board to take up FDI proposals of M&M, Pfizer on FridayMahindra Group's proposal for FDI in defence production and an application by pharma major Pfizer for inducting foreign equity in its compa...
- Delist hopeful Fresenius Kabi Oncology plunges 20% after company's share sale offerFresenius shares crashed 20% after its foreign parent's proposed offer for sale through stock exchanges to increase the public holding in t...
- CCI seeks changes in Competition Act to deal with all M&AsThe government, he added, should amend the law in such a way so that it can have powers to prescribe different threshold limits for M&As fo...
- Prime Minister Manmohan singh likely to take meeting on FDI in pharmaceutical tomorrowNo consensus could emerge in the report of the committee which had senior officials from the ministries of health, industry law finance bes...
- Let all pharmaceutical mergers and acquisitions be cleared by CCI: Plan panel groupA Planning Commission expert group recommended that all M&As in the pharma industry should be cleared by CCI.
- Heard on the Street: Kabi Oncology soars on delisting talkShares of Fresenius Kabi Oncology were among the top gainers in an otherwise weak market as the market speculated the possibility of a deli...
- DIPP rules out FDI cap in pharma sectorThe Department of Industrial Policy and Promotion has virtually turned down the proposal of the Department of Pharmaceuticals to cap FDI in...
- DoP for FDI cap on pharma sector; DIPP disagreesThe Department of industrial Policy and Promotion (DIPP) has virtually turned down the proposal of the Department of Pharmaceuticals to cap...
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- Singapore firm to acquire 73.27% stake in Dabur PharmaHome grown drug maker Dabur Pharma on Saturday said it will sell 73.27 per cent stake to Fresenius Kabi (Singapore) Pte Ltd for an undisclo...
Load More
